Thermo Fisher Scientific (TMO) Income from Discontinued Operations (2010 - 2017)

Thermo Fisher Scientific (TMO) has reported Income from Discontinued Operations for 8 consecutive years, with -$2.0 million the latest figure, recorded in Q4 2017.

• For the quarter ending Q4 2017, Income from Discontinued Operations rose 25.93% year-over-year to -$2.0 million; the trailing twelve-month figure through Dec 2018 stood at -$2.0 million (up 33.33% YoY), and the FY2017 full-year result was -$3.0 million, changed 0.0% from the prior year.
• Income from Discontinued Operations fell to -$2.0 million in Q4 2017 per TMO's latest filing, from -$1.0 million in the prior quarter.
• Across five years, Income from Discontinued Operations topped out at $1.7 million in Q3 2014 and bottomed at -$5.1 million in Q4 2013.
• Historically, Income from Discontinued Operations has averaged -$1.4 million across 5 years, with a median of -$1.0 million in 2017.
• The sharpest annual moves came in 2014 and 2017: Income from Discontinued Operations soared 1800.0% in 2014, then plunged 400.0% in 2017.
• Over 5 years, Income from Discontinued Operations stood at -$5.1 million in 2013, then soared by 45.1% to -$2.8 million in 2014, then slumped by 32.14% to -$3.7 million in 2015, then grew by 27.03% to -$2.7 million in 2016, then gained by 25.93% to -$2.0 million in 2017.
• According to Business Quant data, Income from Discontinued Operations over the past three periods registered -$2.0 million, -$1.0 million, and -$2.7 million for Q4 2017, Q3 2017, and Q4 2016 respectively.